Sola Diagnostics

  • Diagnostics

The WID®-easy test revolutionises uterine cancer diagnosis by reducing unnecessary surgical procedures by over 90%(!!!).


We are dedicated to sparing six million women annually from unnecessary diagnostic surgery (hysteroscopy & curettage)—and saving €6 billion in healthcare costs.


The WID®-easy test is already on the market in Austria, Switzerland, and the UK.

Address

Innsbruck
Austria

Website

https://www.sola-diagnostics.com/en/

Contact Exhibitor


Loading
View all Partnering Companies

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS